Aging Clinical and Experimental Research

, Volume 10, Issue 3, pp 179–181

Foreword

  • M. Passeri
  • L. Sartori
Article
  • 11 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Riggs B.L., Khosla S., Melton L.J. III: A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J. Bone Miner. Res. 13: 763–773, 1998.PubMedCrossRefGoogle Scholar
  2. 2.
    Bilezikian J.P.: Estrogens and postmenopausal osteoporosis: was Albright right after all? J. Bone Miner. Res. 13: 774–776, 1998.PubMedCrossRefGoogle Scholar
  3. 3.
    Uitterlinden A.G., Burger H., Huang Q., Yue F., McGuigan F.E.A., Grant S.F.A., Hofman A., van Leeuwen J.P.T.M., Pols H.A.P., Ralston S.H.: Relation of alleles of the collagen type Iα1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N. Engl. J. Med. 338: 1016–1021, 1998.PubMedCrossRefGoogle Scholar
  4. 4.
    Prockop D.J.: The genetic trail of osteoporosis. N. Engl. J. Med. 338: 1061–1062, 1998.PubMedCrossRefGoogle Scholar
  5. 5.
    Evans W.J.: What is sarcopenia? J. Gerontol. 50A: 5–8, 1995.CrossRefGoogle Scholar
  6. 6.
    Wolfson L., Judge J., Whipple R., King M.: Strength is a major factor in balance, gait, and the occurrence of falls. J. Gerontol. 50A: 64–67, 1995.CrossRefGoogle Scholar
  7. 7.
    Delmas P.D., Bjarnason N.H., Mitlak B., Ravoux A.C., Shah A.S., Huster W.J., Draper M., Christiansen C.: Effects of raloxifene on bone mineral density, serum cholesterol concentration, and uterine endometrium in postmenopausal women. N. Engl. J. Med. 337: 1641–1647, 1997.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Internal Publishing Switzerland 1998

Authors and Affiliations

  • M. Passeri
  • L. Sartori

There are no affiliations available

Personalised recommendations